Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review

Immune checkpoint inhibitors (ICIs) are increasingly being used in the treatment of advanced human malignancies. ICIs-related adverse events, including pancreatitis and diabetes, have been individually characterized in the literature. The co-occurrence of ICIs-related pancreatitis with diabetes is r...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Wei, Gao, Yang, Shi, Xiaoyan, Zhang, Xiaoran, Zhou, Shan, Zhu, Hongxia, Yan, Wei, Wang, Huanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569069/
https://www.ncbi.nlm.nih.gov/pubmed/37841238
http://dx.doi.org/10.3389/fimmu.2023.1243773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569069/
https://www.ncbi.nlm.nih.gov/pubmed/37841238
http://dx.doi.org/10.3389/fimmu.2023.1243773

Ejemplares similares